Federal contract award
75D30124P00086
THE PROCUREMENT LIST (SEE TABLE BELOW) OF SENTOSA SQ HIV GENOTYPING REAGENTS KITS AND CONSUMABLES FROM VELA DIAGNOSTICS, INC ARE REQUIRED FOR PERFORMING THE FDA-APPROVED NGS HIV-1 DRUG RESISTANCE ASSAY. BECAUSE IT IS AN FDA APPROVED NGS ASSAY, THE SE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 325414 — Biological Product (except Diagnostic) Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $31.2K |
| Current contract value | $31.2K |
| Potential contract value / ceiling | $31.2K |
| Start date | Oct 1, 2024 |
| Current end date | Oct 1, 2024 |
| Potential end date | Oct 1, 2024 |
| Latest award activity | Feb 25, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Feb 25, 2026 | P00002 | $0 | THE PROCUREMENT LIST (SEE TABLE BELOW) OF SENTOSA SQ HIV GENOTYPING REAGENTS KITS AND CONSUMABLES FROM VELA DIAGNOSTICS, INC ARE REQUIRED FOR PERFORMING THE FDA-APPROVED NGS HIV-1 DRUG RESISTANCE ASSAY. BECAUSE IT IS AN FDA APPROVED NGS ASSAY, THE SE |
| Nov 8, 2024 | P00001 | $0 | THE PROCUREMENT LIST (SEE TABLE BELOW) OF SENTOSA SQ HIV GENOTYPING REAGENTS KITS AND CONSUMABLES FROM VELA DIAGNOSTICS, INC ARE REQUIRED FOR PERFORMING THE FDA-APPROVED NGS HIV-1 DRUG RESISTANCE ASSAY. BECAUSE IT IS AN FDA APPROVED NGS ASSAY, THE SE |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Cletus Schafrath | Contact | ztb8@cdc.gov | Source | Aug 26, 2024 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.